Market Analysis of Plant-based Vaccines

Healtcareresearch13 Jan, 2022Health

According to the report, the global plant-based vaccines market was valued at US$ 1.10 Bn in 2020. It is projected to expand at a CAGR of 7.38% from 2021 to 2031. Plant-based vaccine production primarily involves the integration of transgene into the plant cells. The target sequence of the selected antigen is integrated with the vector before being transferred into the expression system. Oral plant-based vaccines are ideal, as the manufacturing process is simple; no additional medical devices are needed for injection; and the antigen immunogenicity and biological activities are preserved in the gastrointestinal tract due to their natural bioencapsulation in a plant cell organelle.